- JP-listed companies
- HEALIOS K.K.
- Dividends
HEALIOS K.K. (4593) Dividends
Market cap
¥49.5B
P/E ratio
Helios develops stem cell treatments for hard-to-treat diseases using both somatic stem cells and iPS cells to create regenerative medicines.
Latest Dividend per Share Forecast
0.00JPY
If you buy 100 shares of HEALIOS K.K., the expected annual dividend is 0 JPY.
- Dividend Yield
- -
- Payout Ratio
- 0.0%
Dividend Policy
<p>We recognize returning profits to shareholders as an important management priority. However, because pharmaceutical development requires substantial upfront investment and extended development periods, our policy is to prioritize securing funds to support ongoing research and development activities for the foreseeable future, and we do not currently plan to pay dividends. Should we implement dividends in the future, we anticipate paying dividends once per year.</p>
Dividend per Share
Payout Ratio
Dividend Yield
Dividend History (Forecasts, Revisions, Actuals)
| Fiscal Year | Type | Interim | Year-End | Total | Payout Ratio |
| FY2026 | Forecast(2026/02/16) | 0 | 0 | 0 | - |
|---|---|---|---|---|---|
| FY2025 | Actual(2026/02/16) | 0 | 0 | 0 | - |
| Forecast(2025/02/14) | 0 | 0 | 0 | - | |
| FY2024 | Actual(2025/02/14) | 0 | 0 | 0 | - |
| Forecast(2024/02/14) | 0 | 0 | 0 | - | |
| FY2023 | Actual(2024/02/14) | 0 | 0 | 0 | - |
| Forecast(2023/02/14) | 0 | 0 | 0 | - | |
| FY2022 | Actual(2023/02/14) | 0 | 0 | 0 | - |
| Forecast(2022/02/14) | 0 | 0 | 0 | - | |
| FY2021 | Actual(2022/02/14) | 0 | 0 | 0 | - |
| Forecast(2021/02/12) | 0 | 0 | 0 | 0.0% | |
| FY2020 | Actual(2021/02/12) | 0 | 0 | 0 | 0.0% |
| Forecast(2020/11/13) | 0 | 0 | 0 | - | |
| FY2019 | Actual(2020/11/13) | 0 | 0 | 0 | - |